Skip to content
Saturday, February 21, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Why I Can’t Stop Watching La La Land February 20, 2026
  • Rabbis of LA | Rabbi Ratner Tried ‘Everything’ First February 20, 2026
  • South Africa pulls out of Venice Biennale — because its selected artist wanted to focus on Gaza February 20, 2026
  • Pro-Palestinian vandalism of London bakery with Jewish roots draws outcry from British Jewish groups February 20, 2026
  • Jan Schakowsky retracts endorsement in a congressional race over candidate’s AIPAC funding February 19, 2026
  • In JFNA’s first ‘State of the Jewish Union’ address, security and antisemitism loom large February 19, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.